(Q40905796)

English

Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

0 references

Michael T Lotze

4

object named as

Lotze MT

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Hiroishi K

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Tüting T

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Tahara H

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1988-1994

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Costimulation of T cells for tumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

The two-signal model of lymphocyte activation twenty-one years later

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Evidence that a kinase distinct from protein kinase C and phosphatidylinositol 3-kinase mediates ligation-dependent serine/threonine phosphorylation of the T-lymphocyte co-stimulatory molecule CD28.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Role of the CD28 receptor in T-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Murine Colon Adenocarcinomas: Methods for Selective Culture In Vitro 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

21 January 2018

IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of interferons and other cytokines in the regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301034

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40905796&oldid=2204077585"